{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:59:37Z","timestamp":1769281177355,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12902-017-0212-4","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T12:00:56Z","timestamp":1507291256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Screening for celiac disease in poorly controlled type 2 diabetes mellitus: worth it or not?"],"prefix":"10.1186","volume":"17","author":[{"given":"Muhammed","family":"Kizilgul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozgur","family":"Ozcelik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selvihan","family":"Beysel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Akinci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyfullah","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bekir","family":"Ucan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmut","family":"Apaydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erman","family":"Cakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,6]]},"reference":[{"key":"212_CR1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.diabres.2012.11.006","volume":"98","author":"L Guariguata","year":"2012","unstructured":"Guariguata L. By the numbers: new estimates from the IDF Diabetes Atlas Update for 2012. Diabetes Res Clin Pract. 2012;98:524\u20135.","journal-title":"Diabetes Res Clin Pract"},{"key":"212_CR2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(03)14027-5","volume":"362","author":"PH Green","year":"2003","unstructured":"Green PH, Jabri B. Coeliac disease. Lancet. 2003;362:383\u201391.","journal-title":"Lancet"},{"issue":"4 Suppl 1","key":"212_CR3","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1053\/j.gastro.2005.02.014","volume":"128","author":"C Dube","year":"2005","unstructured":"Dube C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005;128(4 Suppl 1):S57\u201367.","journal-title":"Gastroenterology"},{"key":"212_CR4","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/apt.12973","volume":"40","author":"P Elfstr\u00f6m","year":"2014","unstructured":"Elfstr\u00f6m P, Sundstr\u00f6m J, Ludvigsson JF. Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes. Aliment Pharmacol Ther. 2014;40:1123\u201332.","journal-title":"Aliment Pharmacol Ther"},{"key":"212_CR5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1586\/egh.09.66","volume":"4","author":"U Volta","year":"2010","unstructured":"Volta U, Fabbri A, Parisi C, Piscaglia M, Caio G, Tovoli F, et al. Old and new serological tests for celiac disease screening. Expert Rev Gastroenterol Hepatol. 2010;4:31\u20135.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"212_CR6","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.cell.2012.02.010","volume":"148","author":"FM Ashcroft","year":"2012","unstructured":"Ashcroft FM, Rorsman P. Diabetes mellitus and the beta cell: the last ten years. Cell. 2012;148:1160\u201371.","journal-title":"Cell"},{"key":"212_CR7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrendo.2013.131","volume":"9","author":"LA Velloso","year":"2013","unstructured":"Velloso LA, Eizirik DL, Cnop M. Type 2 diabetes mellitus\u2014an autoimmune disease? Nat Rev Endocrinol. 2013;9:750\u20135.","journal-title":"Nat Rev Endocrinol"},{"key":"212_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","volume":"46","author":"SE Kahn","year":"2003","unstructured":"Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia. 2003;46:3\u201319.","journal-title":"Diabetologia."},{"key":"212_CR9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","volume":"52","author":"J Spranger","year":"2003","unstructured":"Spranger J, Kroke A, M\u00f6hlig M, Hoffmann K, Bergmann MM, Ristow M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European prospective investigation into cancer and nutrition (EPIC)-potsdam study. Diabetes. 2003;52:812\u20137.","journal-title":"Diabetes"},{"key":"212_CR10","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2337\/db06-1595","volume":"56","author":"DM Tsukumo","year":"2007","unstructured":"Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, et al. Loss of function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes. 2007;56:1986\u201398.","journal-title":"Diabetes"},{"key":"212_CR11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1103160","volume":"306","author":"U Ozcan","year":"2004","unstructured":"Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306:457\u201361.","journal-title":"Science"},{"key":"212_CR12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1523\/JNEUROSCI.2760-08.2009","volume":"29","author":"M Milanski","year":"2009","unstructured":"Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra DE, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci. 2009;29:359\u201370.","journal-title":"J Neurosci"},{"key":"212_CR13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"SL Masters","year":"2010","unstructured":"Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes. Nature Immunol. 2010;11:897\u2013904.","journal-title":"Nature Immunol"},{"key":"212_CR14","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1210\/en.2007-0132","volume":"148","author":"EP Araujo","year":"2007","unstructured":"Araujo EP, De Souza CT, Ueno M, Cintra DE, Bertolo MB, Carvalheira JB, et al. Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes. Endocrinology. 2007;148:991\u20137.","journal-title":"Endocrinology"},{"key":"212_CR15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nm.2353","volume":"17","author":"DA Winer","year":"2011","unstructured":"Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 2011;17:610\u20137.","journal-title":"Nat Med"},{"key":"212_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(09)01201-2","volume":"102","author":"NR Cohen","year":"2009","unstructured":"Cohen NR, Garg S, Brenner MB. Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Adv Immunol. 2009;102:1\u201394.","journal-title":"Adv Immunol"},{"key":"212_CR17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm.2391","volume":"17","author":"K Geddes","year":"2011","unstructured":"Geddes K, Rubino SJ, Magalhaes JG, Streutker C, Le Bourhis L, Cho JH, et al. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat Med. 2011;17:837\u201344.","journal-title":"Nat Med"},{"key":"212_CR18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2796.1998.00256.x","volume":"243","author":"K Sj\u00f6berg","year":"1998","unstructured":"Sj\u00f6berg K, Eriksson KF, Bredberg A, Wassmuth R, Eriksson S. Screening for coeliac disease in adult insulin-dependent diabetes mellitus. J Intern Med. 1998;243:133\u201340.","journal-title":"J Intern Med"},{"key":"212_CR19","first-page":"631","volume":"87","author":"SR Page","year":"1994","unstructured":"Page SR, Lloyd CA, Hill PG, Peacock I, Holmes GK. The prevalence of coeliac disease in adult diabetes mellitus. QJM. 1994;87:631\u20137.","journal-title":"QJM"},{"key":"212_CR20","first-page":"1425","volume":"24","author":"J Tourniaire","year":"1995","unstructured":"Tourniaire J, Guichard-Rode S, Monier JC. Circulating antigliadin antibodies. Prevalence in a diabetic (type 1 or 2) and nondiabetic adult population. Presse Med. 1995;24:1425\u20137.","journal-title":"Presse Med"},{"key":"212_CR21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1749-6632.2002.tb02976.x","volume":"958","author":"A Kanungo","year":"2002","unstructured":"Kanungo A, Shtauvere-Brameus A, Samal KC, Sanjeevi CB. Autoantibodies to tissue transglutaminase in patients from eastern India with malnutrition-modulated diabetes mellitus, insulin-dependent diabetes mellitus, and non-insulin-dependent diabetes mellitus. Ann N Y Acad Sci. 2002;958:232\u20134.","journal-title":"Ann N Y Acad Sci"},{"key":"212_CR22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycemia with macrovascular and microvascular complications of Type 2 diabetes (UKPDS 35): Prospective observational study. BMJ. 2000;321:405\u201312.","journal-title":"BMJ"},{"key":"212_CR23","first-page":"262","volume":"11","author":"AJ Karter","year":"2005","unstructured":"Karter AJ, Moffet HH, Liu J, Parker MM, Ahmed AT, Ferrara A, et al. Achieving good glycemic control: Initiation of new antihyperglycemic therapies in the patient with Type 2 diabetes from the Kaiser Permanente Northern California diabetes registry. Am J Manag Care. 2005;11:262\u201370.","journal-title":"Am J Manag Care"},{"key":"212_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2337\/diacare.27.1.17","volume":"27","author":"CE Koro","year":"2004","unstructured":"Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among US adults diagnosed with type2 diabetes: A preliminary report. Diabetes Care. 2004;27:17\u201320.","journal-title":"Diabetes Care"},{"key":"212_CR25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/qjmed\/93.6.369","volume":"93","author":"TM Wallace","year":"2000","unstructured":"Wallace TM, Matthews DR. Poor glycemic control in Type 2 diabetes, conspiracy of disease, suboptimal therapy and attitude. Q J M. 2000;93:369\u201374.","journal-title":"Q J M"},{"key":"212_CR26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0016-5085(92)91819-P","volume":"102","author":"MN Marsh","year":"1992","unstructured":"Marsh MN. Gluten, major histocompatibility complex, and the small intestine. Gastroenterology. 1992;102:330\u201354.","journal-title":"Gastroenterology"},{"key":"212_CR27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/diabetes.49.1.32","volume":"49","author":"M Pietropaolo","year":"2000","unstructured":"Pietropaolo M, Barinas-Mitchell E, Pietropaolo SL, Kuller LH, Trucco M. Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes. Diabetes. 2000;49:32\u20138.","journal-title":"Diabetes"},{"key":"212_CR28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI200215318","volume":"110","author":"K Maedler","year":"2002","unstructured":"Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, et al. Glucose-induced \u03b2-cell production of interleukin-1\u03b2 contributes to glucotoxicity in human pancreatic islets. J Clin Invest. 2002;110:851\u201360.","journal-title":"J Clin Invest"},{"key":"212_CR29","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1073\/pnas.0508166103","volume":"103","author":"R Eldor","year":"2006","unstructured":"Eldor R, Yeffet A, Baum K, Doviner V, Amar D, Ben-Neriah Y, et al. Conditional and specific NF-\u03baB blockade protects pancreatic \u03b2 cells from diabetogenic agents. Proc Natl Acad Sci USA. 2006;103:5072\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"212_CR30","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00125-010-1730-z","volume":"53","author":"M Jagannathan","year":"2010","unstructured":"Jagannathan M, McDonnell M, Liang Y, Hasturk H, Hetzel J. Rubin Det al.: Toll-like receptors regulate B-cell cytokine production in patients with diabetes. Diabetologia. 2010;53:1461\u201371.","journal-title":"Diabetologia"},{"key":"212_CR31","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2337\/diabetes.51.4.1088","volume":"51","author":"E Van Exel","year":"2002","unstructured":"Van Exel E, Gussekloo J, de Craen AJ, Fr\u00f6lich M. Bootsma-Van Der Wiel A, Westendorp RG; Leiden 85 Plus Study. Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus Study. Diabetes. 2002;51:1088\u201392.","journal-title":"Diabetes"},{"key":"212_CR32","first-page":"1","volume":"31","author":"JE Folk","year":"1997","unstructured":"Folk JE, Finlaynson JS. The e-(g-glutamyl) lysine cross-link and the catalytic role of transglutaminases. Adv Protein Chem. 1997;31:1\u2013133.","journal-title":"Adv Protein Chem"},{"key":"212_CR33","unstructured":"Dvorcakova M, Macejova D, Pallet V, Higueret P, Vasson MP, Rock E, et al. Transglutaminase and endocrine system (minireview). Endocr Regul. 2002;36:31\u20136."},{"key":"212_CR34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1210\/endo-117-1-237","volume":"117","author":"A Sener","year":"1985","unstructured":"Sener A, Dunlop ME, Gomis R, Matias PC, Malaisse-Lagae F, Malaisse WJ. The role of transglutaminase in insulin release. Study with glycine and sarcosine methylesters. Endocrinology. 1985;117:237\u201342.","journal-title":"Endocrinology"},{"key":"212_CR35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0304-4165(83)90378-1","volume":"8","author":"R Gomis","year":"1983","unstructured":"Gomis R, Sener A, Malaisse-Lagae F, Malaisse WJ. Transglutaminase activity in pancreatic islets. Biochim Biophys Acta. 1983;8:384\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"212_CR36","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ajg.2013.79","volume":"108","author":"A Rubio-Tapia","year":"2013","unstructured":"Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. American College of G. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656\u201376.","journal-title":"Am J Gastroenterol"},{"key":"212_CR37","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1440-1746.2010.06508.x","volume":"26","author":"SK Bhadada","year":"2011","unstructured":"Bhadada SK, Kochhar R, Bhansali A, Dutta U, Kumar PR, Poornachandra KS, et al. Prevalence and clinical profile of celiac disease in type 1 diabetes mellitus in North India. J Gastroenterol Hepatol. 2011;26:378\u201381.","journal-title":"J Gastroenterol Hepatol"},{"key":"212_CR38","first-page":"56","volume":"80","author":"P Usai","year":"1989","unstructured":"Usai P, Cherchi MV, Boi MF, Cirillo R, Santa Cruz G, Solinas MP, et al. Celiac disease in insulin-dependent diabetes mellitus and insulin-independent diabetes mellitus. Recenti Prog Med. 1989;80:56\u20138.","journal-title":"Recenti Prog Med"},{"key":"212_CR39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/08916930601118825","volume":"40","author":"JC S\u00e1nchez","year":"2007","unstructured":"S\u00e1nchez JC, Cabrera-Rode E, Sorell L, Galvan JA, Hernandez A, Molina G, et al. Celiac disease-associated antibodies in persons with latent autoimmune diabetes of adult and type 2 diabetes. Autoimmunity. 2007;40:103\u20137.","journal-title":"Autoimmunity"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-017-0212-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T12:01:17Z","timestamp":1507291277000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-017-0212-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,6]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["212"],"URL":"https:\/\/doi.org\/10.1186\/s12902-017-0212-4","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,6]]},"article-number":"62"}}